Knockout Rat Database Now Available On Line

KORC Website Directed Toward Academic and Pharmaceutical Researchers
 
July 17, 2008 - PRLog -- Transposagen Biopharmaceuticals, Inc. based in Lexington, KY, announced today that the Knockout Rat Database is now available on line at the Knock Out Rat Consortium (KORC) website, sponsored by Transposagen. The database lists available knockout rat models and the corresponding disrupted gene and phenotype if available. The KORC website is directed toward academic and pharmaceutical researchers and the organization has the goal to create at least one rat with a null mutation corresponding to every gene in the rat genome. The direct link for the database is http://www.knockoutrat.org/insertionInfoSummary.php.

“Many pharmaceutical companies believe the rat is a better model than the mouse for human cardiovascular disease, diabetes, arthritis, and many autoimmune, neurological and behavioral disorders,” said Dr. Eric Ostertag, CEO of Transposagen.  “The KORC database will help the pharmaceutical industry and academia identify the appropriate animal models to use for their drug discovery and development research.”

# # #

About Transposagen Biopharmaceuticals
Transposagen Biopharmaceuticals is a privately held biotechnology company based in Lexington, KY. The company is dedicated to providing unique animal models of human diseases for drug discovery and development. The production of animal models is a $1.2 billion/year market and is expected to grow 12% annually through 2010. For more information, visit www.transposagenbio.com.

About KORC
The Knock Out Rat Consortium (KORC) is formed by individuals and institutions interested in the goal of creating knockout rats using multiple different technologies. The members of KORC are world renowned experts in the field of rodent mutagenesis. The animal models created by KORC are available to academic researchers through the National Rat Research and Resource Center (NRRRC) at the University of Missouri. www.knockoutrat.org
End
Transposagen Biopharmaceuticals, Inc. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share